Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD3ζ-ZAP70 signaling axis is a fundamental component of the T-cell receptor (TCR) complex, responsible for converting extracellular antigen recognition into intracellular activation signals [1, 2]. Upon TCR engagement, the immunoreceptor tyrosine-based activation motifs (ITAMs) within the CD3ζ (CD247) cytoplasmic tail are phosphorylated by the Src-family kinase Lck, creating high-affinity docking sites for the tandem SH2 domains of the Zeta-chain-associated protein kinase 70 (ZAP70) [3, 4]. Once recruited and activated, ZAP70 phosphorylates downstream adapter proteins such as the Linker for Activation of T cells (LAT) and SLP-76, which serve as scaffolds for the assembly of a larger signalosome that initiates calcium flux, Ras-MAPK signaling, and NF-κB activation [3]. This complex is a critical therapeutic target; its overactivity is linked to autoimmune disorders and lymphoid malignancies, while its deficiency or dysfunction leads to severe combined immunodeficiency (SCID) [2, 4]. Modern immunotherapy leverages this pathway by incorporating the CD3ζ signaling domain into Chimeric Antigen Receptors (CARs) to drive potent anti-tumor responses in hematologic cancers [5]. Pharmacological modulation includes small-molecule inhibitors of ZAP70 or upstream kinases like Lck to manage inflammatory conditions, prevent transplant rejection, or treat specific leukemias [6, 7]. Additionally, ZAP-70 expression levels serve as a significant prognostic biomarker in chronic lymphocytic leukemia (CLL), correlating with disease progression and patient survival [8].
The mechanism involves the phosphorylation of ITAMs on the CD3ζ chain by Lck, which recruits ZAP70 via its SH2 domains. ZAP70 is then activated by Lck-mediated phosphorylation and subsequently phosphorylates downstream adapters like LAT and SLP-76 to propagate the TCR signal [3, 4].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell surface glycoprotein CD3 zeta chain and Zeta-chain-associated protein kinase 70 complex (CD3ζ-ZAP70 complex).